• Info
  • Insider Ownership

Insider Trading & Ownership of Kenneth Ph.D. Harrison

Location
Boulder, CO
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Kenneth Ph.D. Harrison and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Kenneth Ph.D. Harrison has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value is not available.
  • No recent insider transactions are currently listed.

What Changed

  • Largest disclosed position: Reneo Pharmaceuticals, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Kenneth Ph.D. Harrison

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OKUR Reneo Pharmaceuticals, Inc. Director 08 Apr 2021

There are no insider transactions reported by Kenneth Ph.D. Harrison